환자 체험 테크놀러지 시장 예측(-2031년) : 제품, 기능, 최종사용자, 지역별

The patient experience technology market is projected to grow from USD 0.74 billion in 2026 to USD 1.29 billion by 2031, at a CAGR of 11.8% during the forecast period. The market is entering a new phase of digital transformation as healthcare providers increasingly adopt technology across the patient journey rather than relying on standalone engagement tools.

Growing adoption of AI-powered communication, digital patient portals, virtual care, online appointment scheduling, automated registration, and feedback management is enabling healthcare organizations to improve accessibility, personalization, and patient engagement. Increasing integration of patient experience platforms with EHRs, CRM systems, telehealth platforms, and analytics solutions is further creating opportunities for technology providers. As healthcare organizations place greater emphasis on patient-centric care, convenience, and experience-driven outcomes, demand for scalable and intelligent patient experience solutions is expected to increase substantially over the forecast period.

"The cloud-based segment is projected to register high growth among software/platform segments during the forecast period."

Based on the offerings, the patient experience technology market is segmented into software/platform and services. The software/platform is divided into on-premise, cloud-based, and hybrid. The cloud-based platform is expected to see significant market growth during the forecast period due to its scalability, lower upfront costs, and ability to rapidly deploy updates. Healthcare providers increasingly favor cloud solutions for digital check-ins, telehealth triage, patient portals, and AI-driven personalization. Vendors such as Press Ganey, Qualtrics, and Epic are embedding cloud-native analytics, conversational AI, and ambient listening tools that improve flexibility and care access. For instance, in February 2025, Press Ganey partnered with Microsoft to develop generative AI-powered solutions that combine Press Ganey's dataset of over 7.6 billion patient encounters with Microsoft's AI, cloud, and ambient listening tools. This collaboration enables predictive analytics for patient safety, real-time actionable insights for providers, and secure data sharing via Azure, demonstrating that cloud-based PX platforms are driving personalization, efficiency, and improved patient experience.

Hence, such strategic collaborations underscore the growing role of cloud-based, AI-enabled patient experience platforms in delivering personalized, efficient, and data-driven care across healthcare settings.

"By end user, the healthcare payers segment is expected to grow at the highest CAGR during the forecast period."

By end user, the healthcare payers segment is expected to register the highest CAGR during the forecast period. Payers are increasingly investing in patient experience (PX) platforms to improve member engagement, streamline claims and administrative processes, and enhance overall satisfaction with health plan services. The growing emphasis on value-based care and outcomes-driven reimbursement models is prompting payers to leverage AI, analytics, and patient feedback tools to monitor service quality, predict member needs, and reduce preventable gaps in care.

Digital channels, such as member portals, teletriage, and automated communication tools, are being adopted to provide personalized, real-time support, improve adherence to preventive care, and strengthen patient loyalty. Additionally, regulatory mandates for interoperability and patient access, such as the US Cures Act and Europe's EHDS, are accelerating payer adoption of patient experience technologies. As a result, payers are emerging as a key growth driver in the market, reflecting their strategic focus on member experience and outcomes.

"North America is expected to hold the largest market share."

North America represents the leading regional market, supported by a well-established healthcare IT infrastructure, high adoption of digital health technologies, and a strong presence of leading patient experience technology providers. Healthcare organizations across the region are increasingly investing in digital patient engagement, patient portals, virtual care, automated communication, feedback management, and AI-enabled experience analytics to improve patient satisfaction and operational efficiency. The growing emphasis on patient-centric care, value-based healthcare, interoperability, and consumer-oriented healthcare delivery is further supporting adoption. In addition, continued investments by healthcare providers and technology companies in AI-powered personalization and digital front-door capabilities are strengthening the regional ecosystem. These factors are expected to maintain North America's leading position in the patient experience technology market over the forecast period.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1: 32%, Tier 2: 44%, and Tier 3: 24%
• By Designation - Directors: 30%, Managers: 34%, and Others: 36%
• By Region - North America: 40%, Europe: 28%, Asia Pacific: 20%, Latin America: 7%, and Middle East & Africa: 5%

Key Players

The key players operating in the patient experience technology market include Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), and Salesforce, Inc. (US). These companies have adopted strategies such as strategic partnerships, collaborations, product launches, platform enhancements, investments in foundation models and generative AI, mergers and acquisitions, and geographic expansion to strengthen their market presence in the patient experience technology market.

Research Coverage

The report analyzes the patient experience technology market. It estimates the market size and future growth potential of various market segments based on offerings, function, end user, and region. The report also analyzes factors such as drivers, restraints, opportunities, and challenges influencing market growth. It evaluates opportunities across the patient experience technology ecosystem and assesses the competitive landscape for key stakeholders. The report also analyzes micro markets by growth trends, prospects, and contributions to the overall patient experience technology market. It forecasts market revenue across major regions and provides a comprehensive competitive analysis of leading market participants, including their company profiles, product portfolios, recent developments, and key growth strategies.

Reasons to Buy the Report

This report will help established firms and new entrants/smaller firms gauge the pulse of the market, which can help them gain a greater market share. Firms purchasing the report could use one or more of the following strategies to strengthen their market position.

This report provides insights on:

• Analysis of key drivers (rising demand for digital engagement platforms and personalized patient care, increasing adoption of telehealth, mobile health apps, and AI-powered analytics, government initiatives and funding to accelerate healthcare digital transformation, growing focus on improving patient satisfaction and long-term engagement through real-time feedback tools, and expansion of cloud-based engagement platforms), restraints (data privacy and cybersecurity concerns restricting adoption, high implementation and integration costs for healthcare providers, limited interoperability between patient engagement systems and existing EHRs), opportunities (expansion in emerging markets with growing healthcare infrastructure, adoption of AI-driven personalization and predictive analytics for patient care, rising partnerships with pharma and payers to accelerate digital health adoption, and growing VR/AR platforms for enhanced patient education and adherence), and challenges (ensuring accuracy and reliability of patient feedback data and rapid technological evolution requiring continuous updates and training) influencing the growth of the patient experience technology market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the patient experience technology market
• Market Development: Comprehensive information on the lucrative emerging markets, by offerings, functions, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient experience technology market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient experience technology market such as Press Ganey (US), National Research Corporation (NRC Health) (US), Medallia Inc. (US), Phreesia (US), NiCE (Israel), R1 RCM Inc. (US), Epic Systems Corporation (US), IQVIA (US), Qualtrics (US), Relias LLC (US), GetWellNetwork (US), CipherHealth Inc. (US), Kyruus, Inc. (US), Twilio Inc. (US), Relatient (US), Alida (Canada), Certify Health (US), Avaamo (US), Luma Health Inc. (US), Solutionreach (US), Salesforce, Inc. (US), Vital (US), NexHealth (US), Collectly, Inc. (US), Business Integrity Services (US), and Bamboo Health (US)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 MARKET SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS
• 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS SHAPING THE MARKET
• 2.4 HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS
• 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 PATIENT EXPERIENCE TECHNOLOGY MARKET OVERVIEW
• 3.2 NORTH AMERICA: PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING & REGION
• 3.3 PATIENT EXPERIENCE TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rising demand for digital engagement platforms and personalized patient care
    • 4.2.1.2 Increasing adoption of telehealth, mobile health apps, and AI-powered analytics
    • 4.2.1.3 Government initiatives and funding for healthcare digital transformation
    • 4.2.1.4 Growing focus on improving patient satisfaction and long-term engagement
    • 4.2.1.5 Expansion of cloud-based engagement platforms
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Data privacy and cybersecurity concerns
    • 4.2.2.2 High implementation and integration costs for healthcare providers
    • 4.2.2.3 Limited interoperability between patient engagement systems and existing electronic health record systems
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Growth opportunities in emerging market
    • 4.2.3.2 Adoption of AI-driven personalization and predictive analytics for patient care
    • 4.2.3.3 Strategic partnerships among technology providers, pharma companies, and payers
    • 4.2.3.4 Rising adoption of virtual reality and augmented reality
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Need to ensure accuracy and reliability of feedback data
    • 4.2.4.2 Rapid technological evolution
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
• 5.2 BARGAINING POWER OF SUPPLIERS
• 5.3 BARGAINING POWER OF BUYERS
• 5.4 THREAT OF NEW ENTRANTS
• 5.5 THREAT OF SUBSTITUTES
• 5.6 INTENSITY OF COMPETITIVE RIVALRY
• 5.7 MACROECONOMIC INDICATORS
  • 5.7.1 INTRODUCTION
  • 5.7.2 GDP TRENDS AND FORECAST
  • 5.7.3 HEALTHCARE DIGITALIZATION AND PATIENT ENGAGEMENT ADOPTION TRENDS
• 5.8 VALUE CHAIN ANALYSIS
  • 5.8.1 PRODUCT DESIGN & DEVELOPMENT
  • 5.8.2 SYSTEM INTEGRATION & WORKFLOW CUSTOMIZATION
  • 5.8.3 IMPLEMENTATION & CHANGE MANAGEMENT
  • 5.8.4 EXPERIENCE ANALYTICS & REPORTING INSIGHTS
  • 5.8.5 POST-SALES SUPPORT & CONTINUOUS IMPROVEMENT
• 5.9 ECOSYSTEM ANALYSIS
• 5.10 PRICING ANALYSIS
  • 5.10.1 AVERAGE SELLING PRICE TREND, BY KEY PLAYER
  • 5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
• 5.11 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.13 INVESTMENT AND FUNDING SCENARIO
• 5.14 CASE STUDY ANALYSIS
• 5.15 IMPACT OF 2025 US TARIFFS ON PATIENT EXPERIENCE TECHNOLOGY MARKET
  • 5.15.1 INTRODUCTION
  • 5.15.2 KEY TARIFF RATES
  • 5.15.3 IMPACT ON COUNTRY/REGION
    • 5.15.3.1 US
    • 5.15.3.2 Europe
    • 5.15.3.3 Asia Pacific
  • 5.15.4 IMPACT ON END USERS
    • 5.15.4.1 Healthcare providers
    • 5.15.4.2 Healthcare payers
    • 5.15.4.3 Pharma & biotech companies
    • 5.15.4.4 Others

6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 VOICE-OF-THE-PATIENT (VOP) PLATFORMS
  • 6.1.2 TELEHEALTH AND VIRTUAL CARE PLATFORMS
  • 6.1.3 PATIENT PORTALS AND PERSONAL HEALTH RECORDS
  • 6.1.4 REMOTE PATIENT MONITORING (RPM)
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 INTEROPERABILITY/API AND FHIR INFRASTRUCTURE
  • 6.2.2 PATIENT IDENTITY MANAGEMENT AND AUTHENTICATION SYSTEMS
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 CLINICAL DECISION SUPPORT SYSTEMS (CDSS)
  • 6.3.2 POPULATION HEALTH MANAGEMENT (PHM) PLATFORMS
  • 6.3.3 PATIENT ENGAGEMENT SOLUTIONS
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
• 6.5 PATENT ANALYSIS
  • 6.5.1 PATENT PUBLICATION TRENDS
  • 6.5.2 JURISDICTION ANALYSIS
  • 6.5.3 MAJOR PATENTS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 AI-POWERED DIGITAL FRONT DOOR AND INTELLIGENT PATIENT NAVIGATION
  • 6.6.2 PREDICTIVE AND PROACTIVE PATIENT EXPERIENCE MANAGEMENT
  • 6.6.3 PERSONALIZED, OMNICHANNEL, AND CONNECTED PATIENT ENGAGEMENT

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY ANALYSIS
    • 7.1.1.1 Regulatory bodies, government agencies, and other organizations
  • 7.1.2 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 INTRODUCTION
• 8.2 DECISION-MAKING PROCESS
• 8.3 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.3.2 KEY BUYING CRITERIA
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
  • 8.4.1 UNMET NEEDS
  • 8.4.2 END-USER EXPECTATIONS
• 8.5 MARKET PROFITABILITY

9 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY FUNCTION

• 9.1 INTRODUCTION
• 9.2 APPOINTMENT SCHEDULING
  • 9.2.1 ENABLING OPERATIONAL EFFICIENCY AND PATIENT ACCESS
• 9.3 PATIENT REGISTRATION
  • 9.3.1 OPTIMIZING FRONT-END WORKFLOWS AND DATA ACCURACY
• 9.4 VIRTUAL CARE
  • 9.4.1 EXPANDING REMOTE ACCESS AND CONTINUITY OF CARE
• 9.5 PATIENT COMMUNICATION
  • 9.5.1 DRIVING PATIENT ACTIVATION AND CARE ADHERENCE
• 9.6 BILLING
  • 9.6.1 PUSH FOR TRANSPARENT & AUTOMATED FINANCIAL WORKFLOWS
• 9.7 FEEDBACK MANAGEMENT
  • 9.7.1 FACILITATING CONTINUOUS IMPROVEMENT IN PATIENT EXPERIENCE
• 9.8 OTHER FUNCTIONS
  • 9.8.1 GROWING FOCUS ON HOLISTIC, PATIENT-CENTRIC CARE

10 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY OFFERING

• 10.1 INTRODUCTION
• 10.2 SOFTWARE
  • 10.2.1 ON-PREMISE SOFTWARE
    • 10.2.1.1 Ensuring data control, compliance, and system integration
  • 10.2.2 CLOUD-BASED
    • 10.2.2.1 Lower upfront costs and seamless interoperability to aid growth
  • 10.2.3 HYBRID SOFTWARE
    • 10.2.3.1 Ability to ensure maximum compliance and control to boost market
• 10.3 SERVICES
  • 10.3.1 MANAGED SERVICES
    • 10.3.1.1 Rising demand for operational efficiency and risk mitigation to encourage growth
  • 10.3.2 PROFESSIONAL SERVICES
    • 10.3.2.1 Need for continuous patient engagement to contribute to growth

11 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY END USER

• 11.1 INTRODUCTION
  • 11.1.1 HEALTHCARE PROVIDERS
    • 11.1.1.1 Growing patient expectations and digital-first strategies
  • 11.1.2 HOSPITALS & HEALTH SYSTEMS
    • 11.1.2.1 Enterprise-wide digital platforms to unify patient journeys and optimize value-based care
  • 11.1.3 OUTPATIENT & AMBULATORY CARE CENTERS
    • 11.1.3.1 Digital transformation elevates patient experience in ambulatory settings
  • 11.1.4 PHYSICIAN & GROUP PRACTICES
    • 11.1.4.1 AI, EHRs, and mobile apps transform care delivery in group practices
  • 11.1.5 LONG-TERM CARE & POST-ACUTE FACILITIES
    • 11.1.5.1 Enhancing care quality and patient experience in LTC and PAC Facilities
  • 11.1.6 OTHER HEALTHCARE PROVIDERS
    • 11.1.6.1 Improving patient engagement and care efficiency across specialty and ambulatory settings to drive segment
• 11.2 HEALTHCARE PAYERS
  • 11.2.1 ADVANCING MEMBER-CENTRIC CARE TO BOOST GROWTH
• 11.3 PHARMA & BIOTECH COMPANIES
  • 11.3.1 PHARMA & BIOTECH ADVANCING PATIENT EXPERIENCE THROUGH DIGITAL SOLUTIONS
• 11.4 OTHER END USERS
  • 11.4.1 ENABLERS OF STANDARDS, COMPLIANCE, AND INNOVATION DRIVING PATIENT EXPERIENCE TECHNOLOGY ADOPTION

12 PATIENT EXPERIENCE TECHNOLOGY MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 US to dominate global market for patient experience technology
  • 12.2.3 CANADA
    • 12.2.3.1 Advancing patient-centric digital health solutions
• 12.3 EUROPE
  • 12.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 12.3.2 UK
    • 12.3.2.1 NHS-driven patient-centric innovation
  • 12.3.3 GERMANY
    • 12.3.3.1 Digital health leadership and patient engagement
  • 12.3.4 FRANCE
    • 12.3.4.1 Advancing patient-centric digital health
  • 12.3.5 ITALY
    • 12.3.5.1 Regional growth and telemedicine expansion
  • 12.3.6 SPAIN
    • 12.3.6.1 Patient-centric digital health and regional innovation
  • 12.3.7 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 JAPAN
    • 12.4.2.1 Rapidly growing elderly population to propel market expansion
  • 12.4.3 CHINA
    • 12.4.3.1 Widespread super-app integration to accelerate adoption
  • 12.4.4 INDIA
    • 12.4.4.1 National digital health programs accelerating market growth in India
  • 12.4.5 SOUTH KOREA
    • 12.4.5.1 Regulatory liberalization and ICT integration fueling market growth
  • 12.4.6 AUSTRALIA
    • 12.4.6.1 Mature healthcare system and digital infrastructure driving adoption
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Brazil to dominate patient experience technology market in Latin America
  • 12.5.3 MEXICO
    • 12.5.3.1 Mexico emerges as a hub for retail-integrated and multilingual patient experience platforms
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Rising healthcare investments to fuel uptake
    • 12.6.2.2 Saudi Arabia
      • 12.6.2.2.1 Vision 2030 and MoH digital-first strategy
    • 12.6.2.3 UAE
      • 12.6.2.3.1 Government-led digital transformation and private-sector innovation
    • 12.6.2.4 Rest of GCC
      • 12.6.2.4.1 Rising demand for telehealth & virtual care
  • 12.6.3 SOUTH AFRICA
  • 12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT EXPERIENCE TECHNOLOGY MARKET
• 13.3 REVENUE ANALYSIS, 2021-2025
• 13.4 MARKET SHARE ANALYSIS, 2025
• 13.5 COMPANY VALUATION AND FINANCIAL METRICS
• 13.6 BRAND/SOFTWARE COMPARISON
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
  • 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.7.5.1 Company footprint
    • 13.7.5.2 Region footprint
    • 13.7.5.3 Offering footprint
    • 13.7.5.4 Function footprint
    • 13.7.5.5 End user footprint
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE BENCHMARKING OF STARTUPS/SMES, 2025
    • 13.8.5.1 Detailed list of key startups/SMEs
    • 13.8.5.2 Competitive benchmarking of key startups/SMEs
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 SOLUTION/SERVICE LAUNCHES
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 PRESS GANEY
    • 14.1.1.1 Business overview
    • 14.1.1.2 Solutions offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Solution launches and enhancements
      • 14.1.1.3.2 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 NATIONAL RESEARCH CORPORATION
    • 14.1.2.1 Business overview
    • 14.1.2.2 Solutions offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Solution launches and enhancements
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses and competitive threats
  • 14.1.3 MEDALLIA INC.
    • 14.1.3.1 Business overview
    • 14.1.3.2 Solutions offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Solution launches and enhancements
      • 14.1.3.3.2 Deals
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses and competitive threats
  • 14.1.4 PHREESIA
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Solution launches and enhancements
      • 14.1.4.3.2 Deals
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses and competitive threats
  • 14.1.5 NICE
    • 14.1.5.1 Business overview
    • 14.1.5.2 Solutions offered
    • 14.1.5.3 MnM view
      • 14.1.5.3.1 Right to win
      • 14.1.5.3.2 Strategic choices
      • 14.1.5.3.3 Weaknesses and competitive threats
  • 14.1.6 R1
    • 14.1.6.1 Business overview
    • 14.1.6.2 Solutions offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Solution launches and enhancements
      • 14.1.6.3.2 Deals
  • 14.1.7 EPIC SYSTEMS CORPORATION
    • 14.1.7.1 Business overview
    • 14.1.7.2 Solutions offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Solution launches and enhancements
      • 14.1.7.3.2 Deals
  • 14.1.8 IQVIA
    • 14.1.8.1 Business overview
    • 14.1.8.2 Solutions offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Solution launches and enhancements
  • 14.1.9 QUALTRICS
    • 14.1.9.1 Business overview
    • 14.1.9.2 Solutions offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Deals
      • 14.1.9.3.2 Expansions
      • 14.1.9.3.3 Other developments
  • 14.1.10 RELIAS LLC
    • 14.1.10.1 Business overview
    • 14.1.10.2 Solutions offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Deals
  • 14.1.11 GETWELLNETWORK, INC.
    • 14.1.11.1 Business overview
    • 14.1.11.2 Solutions offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Solution launches and enhancements
      • 14.1.11.3.2 Deals
  • 14.1.12 CIPHERHEALTH INC.
    • 14.1.12.1 Business overview
    • 14.1.12.2 Solutions offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Solution launches and enhancements
      • 14.1.12.3.2 Deals
  • 14.1.13 KYRUUS, INC.
    • 14.1.13.1 Business overview
    • 14.1.13.2 Solutions offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Solution launches and enhancements
      • 14.1.13.3.2 Deals
  • 14.1.14 RELATIENT
    • 14.1.14.1 Business overview
    • 14.1.14.2 Solutions offered
    • 14.1.14.3 Recent developments
      • 14.1.14.3.1 Solution launches and enhancements
  • 14.1.15 ALIDA
    • 14.1.15.1 Business overview
    • 14.1.15.2 Solutions offered
  • 14.1.16 TWILIO INC.
    • 14.1.16.1 Business overview
    • 14.1.16.2 Solutions offered
    • 14.1.16.3 Recent developments
      • 14.1.16.3.1 Solution launches and enhancements
      • 14.1.16.3.2 Deals
  • 14.1.17 AVAAMO
    • 14.1.17.1 Business overview
    • 14.1.17.2 Products offered
    • 14.1.17.3 Recent developments
      • 14.1.17.3.1 Solution launches and enhancements
  • 14.1.18 CERTIFY HEALTH
    • 14.1.18.1 Business overview
    • 14.1.18.2 Solutions offered
    • 14.1.18.3 Recent developments
      • 14.1.18.3.1 Other developments
  • 14.1.19 LUMA HEALTH INC.
    • 14.1.19.1 Business overview
    • 14.1.19.2 Solutions offered
    • 14.1.19.3 Recent developments
      • 14.1.19.3.1 Solution launches and enhancements
      • 14.1.19.3.2 Deals
  • 14.1.20 SOLUTIONREACH
    • 14.1.20.1 Business overview
    • 14.1.20.2 Solutions offered
    • 14.1.20.3 Recent developments
      • 14.1.20.3.1 Solution launches and enhancements
  • 14.1.21 SALESFORCE, INC.
    • 14.1.21.1 Business overview
    • 14.1.21.2 Solutions offered
    • 14.1.21.3 Recent developments
      • 14.1.21.3.1 Solution launches and enhancements
• 14.2 OTHER PLAYERS
  • 14.2.1 VITAL
  • 14.2.2 NEXHEALTH
  • 14.2.3 COLLECTLY, INC.
  • 14.2.4 BUSINESS INTEGRITY SERVICES
  • 14.2.5 BAMBOO HEALTH

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Key data from primary sources
    • 15.1.2.2 Breakdown of primary sources
• 15.2 RESEARCH METHODOLOGY DESIGN
• 15.3 MARKET SIZE ESTIMATION
• 15.4 MARKET BREAKDOWN & DATA TRIANGULATION
• 15.5 RESEARCH ASSUMPTIONS
  • 15.5.1 MARKET SIZING ASSUMPTIONS
  • 15.5.2 OVERALL STUDY ASSUMPTIONS
• 15.6 RISK ASSESSMENT
• 15.7 RESEARCH LIMITATIONS
  • 15.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 15.7.2 SCOPE-RELATED LIMITATIONS

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS